Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | I-CBP112 |
Trade Name | |
Synonyms | |
Drug Descriptions |
I-CBP112 is a small molecule that selectively inhibits the bromodomains of CREBBP and EP300, potentially resulting in decreased tumor cell growth (PMID: 26552700, PMID: 27673482). |
DrugClasses | CBP/p300 inhibitor 13 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Doxorubicin + I-CBP112 | Doxorubicin I-CBP112 | 1 | 0 |
I-CBP112 | I-CBP112 | 0 | 0 |
I-CBP112 + JQ1 | I-CBP112 JQ1 | 1 | 0 |